RoslinCT is a contract manufacturing organisation focused on providing tailored process development services and robust GMP manufacturing solutions for companies developing cell-based therapeutics for clinical trials.
Supporting you at every step of your advanced therapy journey.
18 October 2018
RoslinCT, a leading cell and gene therapy contract manufacturing organisation, is delighted to announce the appointment of Ian McCubbin OBE to the Board of Directors. Ian is a prominent figure within the Advanced Therapy community and brings a wealth of industry experience to the position
10 October 2018
ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, today announced it is to receive a £1.2 million investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a project which will develop a faster, more cost-effective method of producing clinical-grade induced pluripotent stem cells (iPSCs). The investment comes from Innovate UK’s Medicines Manufacturing Round 2 competition, as part of the UK Government investment strategy
16 April 2018
RoslinCT, a UK-based cell and gene therapy contract manufacturing organisation, is delighted to be part of the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) consortium. As an industry partner within the consortium, RoslinCT will provide advice on the development, manufacture and clinical supply of cell, gene and tissue engineered therapies.
about 16 hours ago
09:41 am Jan 8th
2018 was a great year for the cell and gene therapy industry. Looking forward to an amazing 2019! https://t.co/N2A9NeJf2V
11:08 am Dec 21st